|Bid||0.00 x 1100|
|Ask||0.00 x 1000|
|Day's range||235.27 - 239.85|
|52-week range||215.90 - 277.29|
|Beta (5Y monthly)||0.56|
|PE ratio (TTM)||44.97|
|Earnings date||03 May 2023 - 08 May 2023|
|Forward dividend & yield||3.64 (1.48%)|
|Ex-dividend date||09 Mar 2023|
|1y target est||275.23|
Here are two Dividend Aristocrats that are top-rated Zacks stocks at the moment and can offer unique exposure and diversification to investors' portfolios.
BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.
PacBio's (PACB) new informatics analysis method, Paraphase, will enable researchers to genotype gene paralogs and pseudogenes with high accuracy.